US 7829693
Compositions and methods for inhibiting expression of a target gene
granted A61KA61K38/00A61P
Quick answer
US patent 7829693 (Compositions and methods for inhibiting expression of a target gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00, A61P, A61P25/28, A61P31/12